-
1
-
-
0031471941
-
Elevated fasting total plasma homocysteine levels and cardiovascular disease outcomes in maintenance dialysis patients. A prospective study
-
Bostom AG, Shemin D, Verhoef P et al. Elevated fasting total plasma homocysteine levels and cardiovascular disease outcomes in maintenance dialysis patients. A prospective study. Arterioscler Thromb Vasc Biol 1997; 17: 2554-2558
-
(1997)
Arterioscler. Thromb. Vasc. Biol.
, vol.17
, pp. 2554-2558
-
-
Bostom, A.G.1
Shemin, D.2
Verhoef, P.3
-
2
-
-
0034816582
-
Treatment of hyperhomocysteinemia in end-stage renal disease
-
Shemin D, Bostom A, Selhub J. Treatment of hyperhomocysteinemia in end-stage renal disease. Am J Kidney Dis 2001; 38: S91-S94
-
(2001)
Am. J. Kidney Dis.
, vol.38
-
-
Shemin, D.1
Bostom, A.2
Selhub, J.3
-
3
-
-
0033554459
-
Role of oxidant stress in endothelial dysfunction produced by experimental hyperhomocyst(e)inemia in humans
-
Kanani P, Sinkey C, Browning R, Allaman M, Knapp H, Haynes W. Role of oxidant stress in endothelial dysfunction produced by experimental hyperhomocyst(e)inemia in humans. Circulation 1999; 100: 1161-1168
-
(1999)
Circulation
, vol.100
, pp. 1161-1168
-
-
Kanani, P.1
Sinkey, C.2
Browning, R.3
Allaman, M.4
Knapp, H.5
Haynes, W.6
-
4
-
-
0028210390
-
Enhanced LDL oxidation in uremic patients: An additional mechanism for accelerated atherosclerosis?
-
Maggi E, Bellazzi R, Falaschi F et al. Enhanced LDL oxidation in uremic patients: an additional mechanism for accelerated atherosclerosis? Kidney Int 1994; 45: 876-883
-
(1994)
Kidney Int.
, vol.45
, pp. 876-883
-
-
Maggi, E.1
Bellazzi, R.2
Falaschi, F.3
-
5
-
-
0026333959
-
Role of oxidised low density lipoprotein in atherogenesis
-
Witztum JL, Steinberg D. Role of oxidised low density lipoprotein in atherogenesis. J Clin Invest 1991; 88: 1785-1792
-
(1991)
J. Clin. Invest.
, vol.88
, pp. 1785-1792
-
-
Witztum, J.L.1
Steinberg, D.2
-
6
-
-
0030956673
-
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
-
Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997; 336: 973-979
-
(1997)
N. Engl. J. Med.
, vol.336
, pp. 973-979
-
-
Ridker, P.M.1
Cushman, M.2
Stampfer, M.J.3
Tracy, R.P.4
Hennekens, C.H.5
-
7
-
-
0034783872
-
Inflammation, not hyperhomocysteinemia, is related to oxidative stress and hemostatic and endothelial dysfunction in uremia
-
Mezzano D, Pais EO, Aranda E et al. Inflammation, not hyperhomocysteinemia, is related to oxidative stress and hemostatic and endothelial dysfunction in uremia. Kidney Int 2001; 60: 1844-1850
-
(2001)
Kidney Int.
, vol.60
, pp. 1844-1850
-
-
Mezzano, D.1
Pais, E.O.2
Aranda, E.3
-
10
-
-
0035163912
-
Homocysteine and lipid peroxidation in haemodialysis: Role of folic acid and vitamin E
-
Bayés B, Pastor MC, Bonal J, Juncà J, Romero R. Homocysteine and lipid peroxidation in haemodialysis: role of folic acid and vitamin E. Nephrol Dial Transplant 2001; 16: 2172-2175
-
(2001)
Nephrol. Dial. Transplant
, vol.16
, pp. 2172-2175
-
-
Bayés, B.1
Pastor, M.C.2
Bonal, J.3
Juncà, J.4
Romero, R.5
-
11
-
-
0035116514
-
Autoantibodies to oxidised low-density lipoprotein in coronary artery disease
-
Sherer Y, Tenenbaum A, Blank M et al. Autoantibodies to oxidised low-density lipoprotein in coronary artery disease. Am J Hypertens 2001; 14: 149-154
-
(2001)
Am. J. Hypertens.
, vol.14
, pp. 149-154
-
-
Sherer, Y.1
Tenenbaum, A.2
Blank, M.3
-
12
-
-
0031914677
-
Prospective study of hyperhomocysteinemia as an adverse cardiovascular risk factor in end-stage renal disease
-
Moustapha A, Naso A, Nahlawi M et al. Prospective study of hyperhomocysteinemia as an adverse cardiovascular risk factor in end-stage renal disease. Circulation 1998; 97: 138-141
-
(1998)
Circulation
, vol.97
, pp. 138-141
-
-
Moustapha, A.1
Naso, A.2
Nahlawi, M.3
-
13
-
-
0036153990
-
On behalf of the CRREED Investigators. Hyperhomocysteinemia predicts cardiovascular outcomes in hemodialysis patients
-
Mallamaci F, Zoccali C, Tripepi G et al. on behalf of the CRREED Investigators. Hyperhomocysteinemia predicts cardiovascular outcomes in hemodialysis patients. Kidney Int 2002; 61: 609-614
-
(2002)
Kidney Int.
, vol.61
, pp. 609-614
-
-
Mallamaci, F.1
Zoccali, C.2
Tripepi, G.3
-
14
-
-
0033533527
-
Homocyst(e)ine and cardiovascular disease: A critical review of the epidemiologic evidence
-
Eikelboom JW, Lonn E, Genest J Jr, Hankey G, Yusuf S. Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence. Ann Intern Med 1999; 131: 363-375
-
(1999)
Ann. Intern. Med.
, vol.131
, pp. 363-375
-
-
Eikelboom, J.W.1
Lonn, E.2
Genest J., Jr.3
Hankey, G.4
Yusuf, S.5
-
15
-
-
0035720334
-
An MTHFR variant, homocysteine, and cardiovascular comorbidity in renal disease
-
Wrone E, Zehnder J, Hornberger J, McCann L, Coplon N, Fortmann S. An MTHFR variant, homocysteine, and cardiovascular comorbidity in renal disease. Kidney Int 2001; 60: 1106-1113
-
(2001)
Kidney Int.
, vol.60
, pp. 1106-1113
-
-
Wrone, E.1
Zehnder, J.2
Hornberger, J.3
McCann, L.4
Coplon, N.5
Fortmann, S.6
-
16
-
-
0034033115
-
Hyperhomocysteinemia, nutritional status, and cardiovascular disease in hemodialysis patients
-
Suliman ME, Qureshi AR, Barany P et al. Hyperhomocysteinemia, nutritional status, and cardiovascular disease in hemodialysis patients. Kidney Int 2000; 57: 1727-1735
-
(2000)
Kidney Int.
, vol.57
, pp. 1727-1735
-
-
Suliman, M.E.1
Qureshi, A.R.2
Barany, P.3
-
17
-
-
0032914427
-
Enhanced in vivo lipid peroxidation at elevated plasma total homocysteine levels
-
Voutilainen S, Morrow J, Roberts J et al. Enhanced in vivo lipid peroxidation at elevated plasma total homocysteine levels. Arterioscler Thromb Vasc Biol 1999; 19: 1263-1266
-
(1999)
Arterioscler. Thromb. Vasc. Biol.
, vol.19
, pp. 1263-1266
-
-
Voutilainen, S.1
Morrow, J.2
Roberts, J.3
-
18
-
-
0034702916
-
Does folic acid decrease plasma homocysteine and improve endothelial function in patients with predialysis renal failure?
-
Thambyrajah J, Landray MJ, McGlynn FJ, Jones HJ, Wheeler DC, Townend JN. Does folic acid decrease plasma homocysteine and improve endothelial function in patients with predialysis renal failure? Circulation 2000; 102: 871-875
-
(2000)
Circulation
, vol.102
, pp. 871-875
-
-
Thambyrajah, J.1
Landray, M.J.2
McGlynn, F.J.3
Jones, H.J.4
Wheeler, D.C.5
Townend, J.N.6
-
19
-
-
0036095165
-
5-Methyltetrahydrofolate restores endothelial function in uraemic patients on convective haemodialysis
-
Buccianti G, Raselli S, Baragetti I et al. 5-Methyltetrahydrofolate restores endothelial function in uraemic patients on convective haemodialysis. Nephrol Dial Transplant 2002; 17: 857-864
-
(2002)
Nephrol. Dial. Transplant
, vol.17
, pp. 857-864
-
-
Buccianti, G.1
Raselli, S.2
Baragetti, I.3
-
20
-
-
0035107609
-
Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine model
-
Hofmann MA, Lalla E, Lu Y et al. Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine model. J Clin Invest 2001; 107: 675-683
-
(2001)
J. Clin. Invest.
, vol.107
, pp. 675-683
-
-
Hofmann, M.A.1
Lalla, E.2
Lu, Y.3
-
22
-
-
0032952901
-
Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure
-
Stenvinkel P, Heimbürger O, Paultre F et al. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 1999; 55: 1899-1911
-
(1999)
Kidney Int.
, vol.55
, pp. 1899-1911
-
-
Stenvinkel, P.1
Heimbürger, O.2
Paultre, F.3
-
23
-
-
0036118126
-
Folic acid treatment reduces chemokine release from peripheral blood mononuclear cells in hyperhomocysteinemic subjects
-
Holven K, Aukrust P, Holm T, Ose L, Nenseter M. Folic acid treatment reduces chemokine release from peripheral blood mononuclear cells in hyperhomocysteinemic subjects. Arterioscler Thromb Vasc Biol 2002; 22: 699-703
-
(2002)
Arterioscler. Thromb. Vasc. Biol.
, vol.22
, pp. 699-703
-
-
Holven, K.1
Aukrust, P.2
Holm, T.3
Ose, L.4
Nenseter, M.5
-
24
-
-
0033789815
-
Circulating oxidised low density lipoprotein levels. A biochemical risk marker for coronary heart disease
-
Toshima S, Hasegawa A, Kurabayashi M et al. Circulating oxidised low density lipoprotein levels. A biochemical risk marker for coronary heart disease. Arterioscler Thromb Vasc Biol 2000; 20: 2243-2247
-
(2000)
Arterioscler. Thromb. Vasc. Biol.
, vol.20
, pp. 2243-2247
-
-
Toshima, S.1
Hasegawa, A.2
Kurabayashi, M.3
-
25
-
-
0035901582
-
Elevated levels of oxidised low density lipoprotein show a positive relationship with the severity of acute coronary syndromes
-
Ehara S, Ueda M, Naruko T et al. Elevated levels of oxidised low density lipoprotein show a positive relationship with the severity of acute coronary syndromes. Circulation 2001; 103: 1955-1960
-
(2001)
Circulation
, vol.103
, pp. 1955-1960
-
-
Ehara, S.1
Ueda, M.2
Naruko, T.3
|